Earnings Call · Q3 FY2023·2023-11-09

Q3 23EPS +20.51%·Rev n/aQ2 23EPS -23.73%·Rev n/aQ1 23EPS +100.00%*·Rev n/aQ4 22EPS -40.63%·Rev n/a⚠ consensus missing

Insight Molecular Diagnostics Inc. IMDX

Stephanie Prince — Investor Relations or Communications Officer

Josh Riggs — Chief Executive Officer or Senior Executive

+29.7%1d on move date+30.5% vs SPY3d+32.6%5d+90.4%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more IMDX calls or request research access.

More IMDX calls Browse calls Request research access